Seeing as16 May 2020 15:01
Everyone else is sharing worthless opinions today, talking down the business thought I would add mine. Matt Han**** may as well of said yesterday we have a company making poor table kits which can be used by care home management. The can be used and results reported to improve track and trace. Well that will come in June, maybe before.
Aided by the new dPCR test which will improve output and cost less to make, with less reagents.
Now my view Roche, Thermo, Abbott are nowhere near what novacyt has been doing. On accuracy or on getting the pcr tests quicker, simpler and more commercially available. Whilst novacyt is NOT a one trick pony, they are not impacted in any way by antibody tests. I would not even be surprised if the antibody tests only use is to track and trace. Antibodies in the system is yet to be proven to see if it even helps prevent. What we need right now is a test to see who has it- a quick, reliable and portable test to be operated at doctors surgeries, prisons, schools, care homes, airports, ports. If you think you can talk the company down at a weekend due to a 25% drop in share price- good luck. Bring on £2 if needed as the company is going places, their r&d is second to none, the bigger boys are nowhere near. Now stop all the BS about antibody tests too- Roche released theirs, Uk spunked more money... big deal. Odx still went up 10% yesterday, nullifying you left half arsed argument.